MRI staging of haemodynamic congestion and clinical outcomes - Takeaways - MDSpire

MRI staging of haemodynamic congestion and clinical outcomes

  • By

  • Cesare Mantini

  • Anna Sorella

  • Daniele Falco

  • Darien Calvo Garcia

  • Daniele Petrucci

  • Mauro Gianni Perrucci

  • Sabina Gallina

  • Massimo Caulo

  • Luca Saba

  • Alberto Clemente

  • Mohammed Yunus Khanji

  • Giovanni Donato Aquaro

  • Pankaj Garg

  • Fabrizio Ricci

  • June 10, 2026

  • 0 min

Share

  • 1

    Heart failure affects over 25 million people globally, driven by obesity and diabetes, and is linked to various cardiovascular disorders.

  • 2

    MRI offers a non-invasive method to assess haemodynamic congestion, providing insights into left ventricular filling pressure and central volume distribution.

  • 3

    The study evaluated MRI-derived wedge pressure and pulmonary transit measures in relation to myocardial fibrosis and clinical outcomes.

  • 4

    A simple MRI model integrating left atrial volume and left ventricular mass accurately estimates pulmonary artery wedge pressure.

  • 5

    The study's findings support MRI as a valuable tool for assessing heart failure and predicting patient outcomes.

Original Source(s)

MRI staging of haemodynamic congestion and clinical outcomes

  • by Cesare Mantini, Anna Sorella, Daniele Falco, Darien Calvo Garcia, Daniele Petrucci, Mauro Gianni Perrucci, Sabina Gallina, Massimo Caulo, Luca Saba, Alberto Clemente, Mohammed Yunus Khanji, Giovanni Donato Aquaro, Pankaj Garg, Fabrizio Ricci

  • June 10, 2026

Related Content

Finerenone after FINEARTS-HF: evidence boundaries and implementation in heart failure with LVEF ≥40%

Long-term efficacy and renal safety of SGLT2 inhibitors in patients with heart failure and advanced chronic kidney disease (stage 4): a propensity score-matched retrospective cohort study

Investigational Drug Shows Potentialin Phase 3 Obesity Trial

In a 76-week randomized trial, patients with obesity without diabetes who received survodutide achieved greater weight loss and favorable changes in several metabolic measures compared with those who received placebo.